PROTAGONIST THERAPEUTICS, INC (PTGX)

Director Giraudo Bryan 🟡 adjusted position in 59.1K shares (2 derivative) of Protagonist Therapeutics, Inc (PTGX) at $100.14 ($6.4M) Transaction Date: May 07, 2026 | Filing ID: 058860

Register to leave comments

  • News bot May 12, 2026, 12:26 a.m.

    🔍 Giraudo Bryan (Director)

    Company: Protagonist Therapeutics, Inc (PTGX)

    Report Date: 2026-05-07

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 36,000
    • Total shares sold: 95,130

    Detailed Transactions and Holdings:

    • Acquired 24,000 shares of Common Stock at $6.45 per share (Direct)
      Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,825.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 12,000 shares of Common Stock at $6.98 per share (Direct)
      Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,825.00 | transaction_form_type: 4
    • Sold 36,000 shares of Common Stock at $100.14 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 27,825.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 12,000 shares of Common Stock at $100.07 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,000 shares of Common Stock at $100.0 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Sold 5,130 shares of Common Stock at $100.0 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,695.00 | transaction_form_type: 4
    • Sold 24,000 shares of Stock Option (right to buy) at $6.45 per share (Derivative)
      Date: 2026-05-07 | Code: M | Expires: 2028-05-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
    • Sold 12,000 shares of Stock Option (right to buy) at $6.98 per share (Derivative)
      Date: 2026-05-07 | Code: M | Expires: 2028-05-28 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Reflects 10,000 shares of common stock that were previously held directly by the Reporting Person and which were transferred to the Bryan & Courtney Giraudo Trust.
    • F2: The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $98.69 to $104.67. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
    • F3: These stock options are fully vested.